Amphastar制药（NASDAQ:AMPH）报告其季度每股收益为0.92美元，低于分析师预期的0.94美元，相差2.13%。这是其上一年同期每股收益0.88美元的基础上增长了4.55%。该公司还报告季度销售额为1.865亿美元，低于分析师预期的1.888亿美元，相差1.22%。与去年同期1.78105亿美元的销售额相比，该季度销售额增长了4.71%。
以上内容来自Benzinga Earnings专栏，原文如下：
Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $0.92 per share which missed the analyst consensus estimate of $0.94 by 2.13 percent. This is a 4.55 percent increase over earnings of $0.88 per share from the same period last year. The company reported quarterly sales of $186.500 million which missed the analyst consensus estimate of $188.810 million by 1.22 percent. This is a 4.71 percent increase over sales of $178.105 million the same period last year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.